Global In Vivo CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for In Vivo CRO Market is presumed to reach the market size of nearly USD 10.19 Billion by 2032 from USD 5.06 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vivo cro. The growth and trends of in vivo cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vivo cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Model

Rodent-Based (Rat Models, Mice Models, Other Rodent Models)
Non-Rodent-Based

By Service

Bioanalysis & Dmpk Studies
Toxicity Studies (Glp Toxicology Studies, Non-Glp Toxicology Studies)
Other Services

By Drug Type

Small-Molecule Drugs
Large-Molecule Drugs (Cell & Gene Therapy, Rna Therapy, Other)

By Therapeutic Area

Oncology
Clinical Pharmacology
Cardiology
Infectious Diseases
Neurology
Gastroenterology & Hepatology
Metabolic & Endocrine
Ophthalmology
Autoimmune / Inflammatory Conditions
Other

By End-Use

Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vivo CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vivo CRO market include Biocytogen, Charles River Laboratories International Inc., Crown Bioscience, Evotec, GemPharmatech, IQVIA Inc., Icon Plc, Labcorp Drug Development, Parexel International Corporation, PsychoGenics Inc., Taconic Biosciences, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114389

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IN VIVO CRO - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal Model
- 3.7.2 Market Attractiveness Analysis By Service
- 3.7.3 Market Attractiveness Analysis By Drug Type
- 3.7.4 Market Attractiveness Analysis By Therapeutic Area
- 3.7.5 Market Attractiveness Analysis By End-use
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VIVO CRO MARKET ANALYSIS BY ANIMAL MODEL

5.1. Overview By Animal Model
5.2. Historical and Forecast Data
5.3. Analysis By Animal Model
5.4. Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Historic and Forecast Sales By Regions
5.5. Non-Rodent-Based Historic and Forecast Sales By Regions

6. GLOBAL IN VIVO CRO MARKET ANALYSIS BY SERVICE

6.1. Overview By Service
6.2. Historical and Forecast Data
6.3. Analysis By Service
6.4. Bioanalysis & DMPK Studies Historic and Forecast Sales By Regions
6.5. Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Historic and Forecast Sales By Regions
6.6. Other Services Historic and Forecast Sales By Regions

7. GLOBAL IN VIVO CRO MARKET ANALYSIS BY DRUG TYPE

7.1. Overview By Drug Type
7.2. Historical and Forecast Data
7.3. Analysis By Drug Type
7.4. Small-Molecule Drugs Historic and Forecast Sales By Regions
7.5. Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Historic and Forecast Sales By Regions

8. GLOBAL IN VIVO CRO MARKET ANALYSIS BY THERAPEUTIC AREA

8.1. Overview By Therapeutic Area
8.2. Historical and Forecast Data
8.3. Analysis By Therapeutic Area
8.4. Oncology Historic and Forecast Sales By Regions
8.5. Clinical Pharmacology Historic and Forecast Sales By Regions
8.6. Cardiology Historic and Forecast Sales By Regions
8.7. Infectious Diseases Historic and Forecast Sales By Regions
8.8. Neurology Historic and Forecast Sales By Regions
8.9. Gastroenterology & Hepatology Historic and Forecast Sales By Regions
8.10. Metabolic & Endocrine Historic and Forecast Sales By Regions
8.11. Ophthalmology Historic and Forecast Sales By Regions
8.12. Autoimmune / Inflammatory Conditions Historic and Forecast Sales By Regions
8.13. Other Historic and Forecast Sales By Regions

9. GLOBAL IN VIVO CRO MARKET ANALYSIS BY END-USE

9.1. Overview By End-use
9.2. Historical and Forecast Data
9.3. Analysis By End-use
9.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
9.5. Medical Device Companies Historic and Forecast Sales By Regions
9.6. Academic & Research Institutes Historic and Forecast Sales By Regions

10. GLOBAL IN VIVO CRO MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE IN VIVO CRO COMPANIES

11.1. In Vivo CRO Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF IN VIVO CRO INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Biocytogen
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Charles River Laboratories International Inc.
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Crown Bioscience
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Evotec
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. GemPharmatech
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. IQVIA Inc.
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Icon Plc
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Labcorp Drug Development
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Parexel International Corporation
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. PsychoGenics Inc.
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. Taconic Biosciences Inc.
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies